Association of Facial Paralysis With mRNA COVID-19 Vaccines A Disproportionality Analysis Using the World Health Organization Pharmacovigilance Database

被引:76
|
作者
Renoud, Lucie [1 ]
Khouri, Charles [1 ,2 ,3 ]
Revol, Bruno [1 ,3 ]
Lepelley, Marion [1 ]
Perez, Justine [1 ]
Roustit, Matthieu [2 ,3 ]
Cracowski, Jean-Luc [1 ,3 ]
机构
[1] Grenoble Alpes Univ Hosp, Pharmacovigilance Dept, Grenoble, France
[2] Grenoble Alpes Univ Hosp, Clin Pharmacol Dept, INSERM, CIC1406, Grenoble, France
[3] Univ Grenoble Alpes, INSERM, UMR U1300, HP2 Lab, Grenoble, France
关键词
D O I
10.1001/jamainternmed.2021.2219
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This disproportionality analysis uses the World Health Organization pharmacovigilance database to explore the potential safety signal of facial paralysis after COVID-19 vaccination.
引用
收藏
页码:1243 / 1245
页数:4
相关论文
共 50 条
  • [1] Association of Cerebral Venous Thrombosis with mRNA COVID-19 Vaccines: A Disproportionality Analysis of the World Health Organization Pharmacovigilance Database
    Park, Jin
    Park, Moo-Seok
    Kim, Hyung Jun
    Song, Tae-Jin
    VACCINES, 2022, 10 (05)
  • [2] ASSOCIATION OF CEREBRAL VENOUS THROMBOSIS WITH MRNA COVID-19 VACCINES: A DISPROPORTIONALITY ANALYSIS OF THE WORLD HEALTH ORGANIZATION PHARMACOVIGILANCE DATABASE
    Chang, Y.
    Song, T. -J.
    INTERNATIONAL JOURNAL OF STROKE, 2023, 18 (03) : 335 - 336
  • [3] Association of Cerebral Venous Thrombosis with mRNA COVID--19Vaccines:A Disproportionality Analysis of theWorld Health Organization Pharmacovigilance Database
    Song, Tae-Jin
    CEREBROVASCULAR DISEASES, 2023, 52 : 150 - 150
  • [4] A Disproportionality Analysis for Association of Systemic Capillary Leak Syndrome with COVID-19 Vaccination Using the World Health Organization Pharmacovigilance Database
    Park, Jin
    Kim, Dongyeop
    Song, Tae-Jin
    VACCINES, 2022, 10 (06)
  • [5] Associations of neuralgic amyotrophy with COVID-19 vaccination: Disproportionality analysis using the World Health Organization pharmacovigilance database
    Kim, Jee-Eun
    Park, Jin
    Min, Young Gi
    Hong, Yoon-Ho
    Song, Tae-Jin
    MUSCLE & NERVE, 2022, 66 (06) : 766 - 770
  • [6] A disproportionality analysis for the association of central nervous system demyelinating diseases with COVID-19 vaccination using the World Health Organization pharmacovigilance database
    Kim, Jee-Eun
    Park, Jin
    Song, Tae-Jin
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (13) : 2112 - 2123
  • [7] Impact of the Inclusion of Covid-19 Vaccines in the National Pharmacovigilance Database on the Measurement of Disproportionality
    Talibi, I.
    Tebaa, A.
    Bencheikh, R. S.
    DRUG SAFETY, 2022, 45 (10) : 1182 - 1183
  • [8] Comparative safety of mRNA COVID-19 vaccines to influenza vaccines: A pharmacovigilance analysis using WHO international database
    Kim, Min Seo
    Jung, Se Yong
    Ahn, Jong Gyun
    Park, Se Jin
    Shoenfeld, Yehuda
    Kronbichler, Andreas
    Koyanagi, Ai
    Dragioti, Elena
    Tizaoui, Kalthoum
    Hong, Sung Hwi
    Jacob, Louis
    Salem, Joe-Elie
    Yon, Dong Keon
    Lee, Seung Won
    Ogino, Shuji
    Kim, Hanna
    Kim, Jerome H.
    Excler, Jean-Louis
    Marks, Florian
    Clemens, John D.
    Eisenhut, Michael
    Barnett, Yvonne
    Butler, Laurie
    Ilie, Cristian Petre
    Shin, Eui-Cheol
    Shin, Jae Il
    Smith, Lee
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (03) : 1085 - 1095
  • [9] Safety Profiles of mRNA COVID-19 Vaccines Using World Health Organization Global Scale Database (VigiBase): A Latent Class Analysis
    Min-Taek Lee
    Wonbin Choi
    Seung-Hun You
    Sewon Park
    Jeong-Yeon Kim
    Dal Ri Nam
    Ju Won Lee
    Sun-Young Jung
    Infectious Diseases and Therapy, 2023, 12 : 443 - 458
  • [10] Safety Profiles of mRNA COVID-19 Vaccines Using World Health Organization Global Scale Database (VigiBase): A Latent Class Analysis
    Lee, Min-Taek
    Choi, Wonbin
    You, Seung-Hun
    Park, Sewon
    Kim, Jeong-Yeon
    Nam, Dal Ri
    Lee, Ju Won
    Jung, Sun-Young
    INFECTIOUS DISEASES AND THERAPY, 2023, 12 (02) : 443 - 458